These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34203690)

  • 41. Quenching of quercetin quinone/quinone methides by different thiolate scavengers: stability and reversibility of conjugate formation.
    Awad HM; Boersma MG; Boeren S; Van Bladeren PJ; Vervoort J; Rietjens IM
    Chem Res Toxicol; 2003 Jul; 16(7):822-31. PubMed ID: 12870884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.
    Liu PY; Sokolowski N; Guo ST; Siddiqi F; Atmadibrata B; Telfer TJ; Sun Y; Zhang L; Yu D; Mccarroll J; Liu B; Yang RH; Guo XY; Tee AE; Itoh K; Wang J; Kavallaris M; Haber M; Norris MD; Cheung BB; Byrne JA; Ziegler DS; Marshall GM; Dinger ME; Codd R; Zhang XD; Liu T
    Oncotarget; 2016 Nov; 7(48):79217-79232. PubMed ID: 27764794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam.
    Barnette DA; Schleiff MA; Osborn LR; Flynn N; Matlock M; Swamidass SJ; Miller GP
    Toxicology; 2020 Jul; 440():152478. PubMed ID: 32437779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interindividual Variation in CYP3A Activity Influences Lapatinib Bioactivation.
    Bissada JE; Truong V; Abouda AA; Wines KJ; Crouch RD; Jackson KD
    Drug Metab Dispos; 2019 Nov; 47(11):1257-1269. PubMed ID: 31492693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain.
    Law RP; Atkinson SJ; Bamborough P; Chung CW; Demont EH; Gordon LJ; Lindon M; Prinjha RK; Watson AJB; Hirst DJ
    J Med Chem; 2018 May; 61(10):4317-4334. PubMed ID: 29656650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo.
    Morse MA; Balogh KK; Brendle SA; Campbell CA; Chen MX; Furze RC; Harada IL; Holyer ID; Kumar U; Lee K; Prinjha RK; Rüdiger M; Seal JT; Taylor S; Witherington J; Christensen ND
    Antiviral Res; 2018 Jun; 154():158-165. PubMed ID: 29653131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p-Quinone methides are the major decomposition products of catechol estrogen o-quinones.
    Bolton JL; Shen L
    Carcinogenesis; 1996 May; 17(5):925-9. PubMed ID: 8640939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cells.
    Schilderink R; Bell M; Reginato E; Patten C; Rioja I; Hilbers FW; Kabala PA; Reedquist KA; Tough DF; Tak PP; Prinjha RK; de Jonge WJ
    Mol Immunol; 2016 Nov; 79():66-76. PubMed ID: 27710838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1-(Benzo[b]thiophen-4-yl)piperazine Ring Induced Bioactivation of Brexpiprazole in Liver Microsomes: Identification and Characterization of Reactive Conjugates Using Ultra-High-Performance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry.
    Thakkar D; Kate AS
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):393-403. PubMed ID: 32002811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4.
    Kalgutkar AS; Vaz AD; Lame ME; Henne KR; Soglia J; Zhao SX; Abramov YA; Lombardo F; Collin C; Hendsch ZS; Hop CE
    Drug Metab Dispos; 2005 Feb; 33(2):243-53. PubMed ID: 15523046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quinone methides and their prodrugs: a subtle equilibrium between cancer promotion, prevention, and cure.
    Dufrasne F; Gelbcke M; Neve J; Kiss R; Kraus JL
    Curr Med Chem; 2011; 18(26):3995-4011. PubMed ID: 21824091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioactivation of sitaxentan in liver microsomes, hepatocytes, and expressed human P450s with characterization of the glutathione conjugate by liquid chromatography tandem mass spectrometry.
    Erve JC; Gauby S; Maynard JW; Svensson MA; Tonn G; Quinn KP
    Chem Res Toxicol; 2013 Jun; 26(6):926-36. PubMed ID: 23721565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity.
    Park BK; Laverty H; Srivastava A; Antoine DJ; Naisbitt D; Williams DP
    Chem Biol Interact; 2011 Jun; 192(1-2):30-6. PubMed ID: 20846520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives.
    Feng L; Wang G; Chen Y; He G; Liu B; Liu J; Chiang CM; Ouyang L
    Med Res Rev; 2022 Mar; 42(2):710-743. PubMed ID: 34633088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of Dimethylisoxazole-Attached Imidazo[1,2-
    Muthengi A; Wimalasena VK; Yosief HO; Bikowitz MJ; Sigua LH; Wang T; Li D; Gaieb Z; Dhawan G; Liu S; Erickson J; Amaro RE; Schönbrunn E; Qi J; Zhang W
    J Med Chem; 2021 May; 64(9):5787-5801. PubMed ID: 33872011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated inactivation of reactive quinoneimine metabolites of diclofenac and mefenamic acid.
    Vredenburg G; Elias NS; Venkataraman H; Hendriks DF; Vermeulen NP; Commandeur JN; Vos JC
    Chem Res Toxicol; 2014 Apr; 27(4):576-86. PubMed ID: 24552538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bromodomain and Extra-Terminal (BET) Domain Protein Inhibitors for Solid Tumor Cancers.
    Nguyen MV; Loof L; Falchook GS
    J Immunother Precis Oncol; 2020 Feb; 3(1):16-22. PubMed ID: 35756176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High resolution mass spectrometry-based methodologies for identification of Etravirine bioactivation to reactive metabolites: In vitro and in vivo approaches.
    Godinho ALA; Martins IL; Nunes J; Charneira C; Grilo J; Silva DM; Pereira SA; Soto K; Oliveira MC; Marques MM; Jacob CC; Antunes AMM
    Eur J Pharm Sci; 2018 Jul; 119():70-82. PubMed ID: 29592839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors.
    Sharp PP; Garnier JM; Hatfaludi T; Xu Z; Segal D; Jarman KE; Jousset H; Garnham A; Feutrill JT; Cuzzupe A; Hall P; Taylor S; Walkley CR; Tyler D; Dawson MA; Czabotar P; Wilks AF; Glaser S; Huang DCS; Burns CJ
    ACS Med Chem Lett; 2017 Dec; 8(12):1298-1303. PubMed ID: 29259751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.